Literature DB >> 19299247

Severity assessment in community-acquired pneumonia: a review.

A Singanayagam1, J D Chalmers, A T Hill.   

Abstract

Severity assessment is an important early step in the management of patients presenting with community-acquired pneumonia. Various pneumonia-specific scores, generic sepsis scores and predictive biomarkers have been proposed as tools to aid clinicians in key management decisions. However, there is no uniform agreement about the optimum severity assessment tool to use. This review provides a summary of current evidence surrounding severity assessment in adult patients presenting with community-acquired pneumonia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299247     DOI: 10.1093/qjmed/hcp027

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  20 in total

Review 1.  Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis.

Authors:  Maggie McNally; James Curtain; Kirsty K O'Brien; Borislav D Dimitrov; Tom Fahey
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

2.  Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia.

Authors:  Samuel M Brown; Jason P Jones; Dominik Aronsky; Barbara E Jones; Michael J Lanspa; Nathan C Dean
Journal:  Respirology       Date:  2012-11       Impact factor: 6.424

3.  Role of Semi-quantitative Serum Procalcitonin in Assessing Prognosis of Community Acquired Bacterial Pneumonia Compared to PORT PSI, CURB-65 and CRB-65.

Authors:  Lalita Fernandes; Akashdeep Singh Arora; Anthony Menezes Mesquita
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 4.  Defining severe pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Clin Chest Med       Date:  2011-07-12       Impact factor: 2.878

Review 5.  Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

Authors:  James D Chalmers; Pallavi Mandal; Aran Singanayagam; Ahsan R Akram; Gourab Choudhury; Philip M Short; Adam T Hill
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

6.  Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.

Authors:  Yuan-Hung Yeh; Junn-Liang Chang; Pei-Ching Hsiao; Shih-Ming Tsao; Chien Huang Lin; Shang-Jyh Kao; Ming-Chih Chou; Shun-Fa Yang; Ming-Hsien Chien
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

7.  Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia.

Authors:  Motoi Ugajin; Yu Matsuura; Kei Matsuura; Hiroshi Matsuura
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 8.  Defining and predicting severe community-acquired pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

9.  Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic--Mexico.

Authors:  Eduardo Rodriguez-Noriega; Esteban Gonzalez-Diaz; Rayo Morfin-Otero; Gerardo F Gomez-Abundis; Jaime Briseño-Ramirez; Hector Raul Perez-Gomez; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ernesto Ramírez; Irma López; Miguel Iguala; Ietza Bojórquez Chapela; Ethel Palacios Zavala; Mauricio Hernández; Tammy L Stuart; Margarita Elsa Villarino; Marc-Alain Widdowson; Steve Waterman; Timothy Uyeki; Eduardo Azziz-Baumgartner
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

10.  Serum ficolin-2 in hospitalised patients with community-acquired pneumonia.

Authors:  James D Chalmers; Gilly B Fleming; Julia Rutherford; Misao Matsushita; David C Kilpatrick; Adam T Hill
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.